EBMT 2017: Highlighting the hottest topics in the field of transplantation
Why do charities need to keep funding research into leukemia and blood cancer in general?
Advancements in AML therapy at ASH 2017
Exportin (XPO1) inhibitors for the treatment of AML
PT-1 study update: addition of hydroxyurea to aspirin in essential thrombocythemia